SE312556B - - Google Patents
Info
- Publication number
- SE312556B SE312556B SE14453/66A SE1445366A SE312556B SE 312556 B SE312556 B SE 312556B SE 14453/66 A SE14453/66 A SE 14453/66A SE 1445366 A SE1445366 A SE 1445366A SE 312556 B SE312556 B SE 312556B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00504087A US3821387A (en) | 1965-10-23 | 1965-10-23 | The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles |
| US55687966A | 1966-06-13 | 1966-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE312556B true SE312556B (cg-RX-API-DMAC7.html) | 1969-07-21 |
Family
ID=27054718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE14453/66A SE312556B (cg-RX-API-DMAC7.html) | 1965-10-23 | 1966-10-21 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US3821387A (cg-RX-API-DMAC7.html) |
| CH (1) | CH505824A (cg-RX-API-DMAC7.html) |
| DE (1) | DE1620224A1 (cg-RX-API-DMAC7.html) |
| FR (2) | FR1602626A (cg-RX-API-DMAC7.html) |
| GB (2) | GB1167562A (cg-RX-API-DMAC7.html) |
| NL (1) | NL6615028A (cg-RX-API-DMAC7.html) |
| SE (1) | SE312556B (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3912746A (en) * | 1970-08-28 | 1975-10-14 | American Cyanamid Co | Substituted nitrogen containing heteroethyleneindoles |
| US4160862A (en) * | 1972-06-12 | 1979-07-10 | Sterling Drug Inc. | 1-Acyl-3-(amino-lower-alkyl)indoles |
| US4031221A (en) * | 1974-06-17 | 1977-06-21 | American Hoechst Corporation | Method of treating pain and hypertension |
| US4242347A (en) * | 1979-06-18 | 1980-12-30 | Ciba-Geigy Corporation | Hypotensive indolylalkylpiperidyl guanidines and isoureas |
| US4327103A (en) * | 1980-07-07 | 1982-04-27 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-{3-[4-(4-Fluorobenzoyl)piperidyl]propyl}-2-methyl indole |
| US4977178A (en) * | 1982-09-20 | 1990-12-11 | Pfizer Inc. | Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| US4879391A (en) * | 1982-09-20 | 1989-11-07 | Pfizer Inc. | 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents |
| US4861880A (en) * | 1982-09-20 | 1989-08-29 | Pfizer Inc. | 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| DE3308668A1 (de) * | 1983-03-11 | 1984-09-13 | Merck Patent Gmbh, 6100 Darmstadt | Indolderivate |
| DE3430284A1 (de) * | 1984-08-17 | 1986-02-27 | Troponwerke GmbH & Co KG, 5000 Köln | Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung |
| EP0187619A3 (de) * | 1985-01-03 | 1987-08-26 | Ciba-Geigy Ag | 1,3-disubstituierte Tetrahydropyridine |
| EP0187122A3 (de) * | 1985-01-03 | 1987-12-16 | Ciba-Geigy Ag | 1,3,4-Trisubstituierte Azacycloalkane bzw. Azacycloalkene |
| DE3835291A1 (de) * | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
| US5274097A (en) * | 1988-04-19 | 1993-12-28 | Bayer Aktiengesellschaft | 1,3-disubstituted pyrrolidines |
| SE9603283D0 (sv) * | 1996-09-10 | 1996-09-10 | Astra Ab | New compounds |
| TW472045B (en) * | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
| AR017200A1 (es) | 1997-12-23 | 2001-08-22 | Astrazeneca Ab | Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos |
| SE9800835D0 (sv) | 1998-03-13 | 1998-03-13 | Astra Ab | New Compounds |
| CZ20003985A3 (cs) | 1998-04-28 | 2001-09-12 | Arzneimittelwerk Dresden Gmbh | Nový hydroxyindol, způsob jeho přípravy a jeho použití jako inhibitoru fosfodiesterázy 4 |
| US6492406B1 (en) | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
| US6346625B1 (en) | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
| PT2978763T (pt) * | 2013-03-27 | 2018-04-16 | Viiv Healthcare Uk No 5 Ltd | Derivados de 2-cetoamida como inibidores da ligação do vih |
-
1965
- 1965-10-23 US US00504087A patent/US3821387A/en not_active Expired - Lifetime
-
1966
- 1966-06-13 US US556879A patent/US3642803A/en not_active Expired - Lifetime
- 1966-10-06 GB GB44649/66A patent/GB1167562A/en not_active Expired
- 1966-10-06 GB GB25960/69A patent/GB1167563A/en not_active Expired
- 1966-10-21 SE SE14453/66A patent/SE312556B/xx unknown
- 1966-10-22 FR FR1602626D patent/FR1602626A/fr not_active Expired
- 1966-10-24 NL NL6615028A patent/NL6615028A/xx unknown
- 1966-10-24 CH CH1537666A patent/CH505824A/de not_active IP Right Cessation
- 1966-10-24 DE DE19661620224 patent/DE1620224A1/de active Pending
-
1967
- 1967-01-20 FR FR92054A patent/FR6253M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1167563A (en) | 1969-10-15 |
| CH505824A (de) | 1971-04-15 |
| NL6615028A (cg-RX-API-DMAC7.html) | 1967-04-24 |
| GB1167562A (en) | 1969-10-15 |
| US3821387A (en) | 1974-06-28 |
| US3642803A (en) | 1972-02-15 |
| FR6253M (cg-RX-API-DMAC7.html) | 1968-08-19 |
| FR1602626A (cg-RX-API-DMAC7.html) | 1971-01-04 |
| DE1620224A1 (de) | 1970-02-12 |